Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham ...

US pharma giant Merck & Co (NYSE: MRK) has presented positive results from two pivotal Phase III trials of the ...

The state of Delaware has offered Merck a $30.2 million grant to encourage the company to choose the Wilmington-area location. If Merck accepts the grant, the company would be required to create 375 ...

Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA This news release of Merck ... technological advances, new products and patents attained by competitors; challenges inherent ...

Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA This news release of Merck ... technological advances, new products and patents attained by competitors; challenges inherent ...

Merck's revenue increase was primarily due to raised sales of its anticancer medications, as well as veterinary products ... ends in 2028 only in the USA, while Europe will not see its biosimilars ...

The market for Bavencio (avelumab), the checkpoint inhibitor co-developed by Pfizer (NYSE: PFE) and Merck KGaA (MRK: DE), ...

UF's IPPD program has produced patents, trade secrets and countless innovations for its sponsors, as well as job opportunities for its students.

Ireland hosts the world's ten largest drugmakers, including U.S. companies Johnson & Johnson, Pfizer, and Merck, all of which have large plants on the Emerald Isle. But for how long?

The state-of-the-art biologics facility, acquired by Syngene USA Inc., a wholly owned subsidiary of Syngene, from Emergent ...